Literature DB >> 3894051

Characterisation of HlyC and mechanism of activation and secretion of haemolysin from E. coli 2001.

J M Nicaud, N Mackman, L Gray, I B Holland.   

Abstract

In this paper the DNA sequence of the cloned hlyC gene from E. coli 2001 is presented. The gene encodes a protein of 20 kDa which is able to activate the 107 kDa polypeptide encoded by hlyA. This gives rise to a haemolytically active protein which differs from the inactive form in stability and by its migration when analysed by polyacrylamide gel electrophoresis under non-denaturing conditions. We also show that the inactive form is secreted in the presence of the transport functions hlyB and hlyD. This result rules out any role for the hlyC gene product in the transport of HlyA across the inner membrane.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3894051     DOI: 10.1016/0014-5793(85)81272-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  47 in total

1.  Isolation and characterization of Escherichia coli tolC mutants defective in secreting enzymatically active alpha-hemolysin.

Authors:  H Vakharia; G J German; R Misra
Journal:  J Bacteriol       Date:  2001-12       Impact factor: 3.490

Review 2.  The mechanism of secretion of hemolysin and other polypeptides from gram-negative bacteria.

Authors:  I B Holland; M A Blight; B Kenny
Journal:  J Bioenerg Biomembr       Date:  1990-06       Impact factor: 2.945

3.  Mutations affecting pore formation by haemolysin from Escherichia coli.

Authors:  A Ludwig; A Schmid; R Benz; W Goebel
Journal:  Mol Gen Genet       Date:  1991-04

4.  Characterization of monoclonal antibodies against the Escherichia coli hemolysin.

Authors:  S Pellett; D F Boehm; I S Snyder; G Rowe; R A Welch
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

5.  Mutations in HlyD, part of the type 1 translocator for hemolysin secretion, affect the folding of the secreted toxin.

Authors:  A L Pimenta; K Racher; L Jamieson; M A Blight; I B Holland
Journal:  J Bacteriol       Date:  2005-11       Impact factor: 3.490

6.  Separable domains define target cell specificities of an RTX hemolysin from Actinobacillus pleuropneumoniae.

Authors:  D R McWhinney; Y F Chang; R Young; D K Struck
Journal:  J Bacteriol       Date:  1992-01       Impact factor: 3.490

7.  Characterization of monoclonal antibodies against alpha-hemolysin of Escherichia coli.

Authors:  R L Oropeza-Wekerle; P Kern; D Sun; S Muller; J P Briand; W Goebel
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

8.  Antibodies against hemolysin and cytotoxic necrotizing factor type 1 (CNF1) reduce bladder inflammation in a mouse model of urinary tract infection with toxigenic uropathogenic Escherichia coli.

Authors:  Mark A Smith; Rebecca A Weingarten; Lisa M Russo; Christy L Ventura; Alison D O'Brien
Journal:  Infect Immun       Date:  2015-02-09       Impact factor: 3.441

9.  Partial purification of alpha-hemolysin in Escherichia coli.

Authors:  F Nistiar; V Janigová; J Durovicová; H Puzová
Journal:  Folia Microbiol (Praha)       Date:  1991       Impact factor: 2.099

10.  Hemolytically active (acylated) alpha-hemolysin elicits interleukin-1beta (IL-1beta) but augments the lethality of Escherichia coli by an IL-1- and tumor necrosis factor-independent mechanism.

Authors:  T G Gleason; C W Houlgrave; A K May; T D Crabtree; R G Sawyer; W Denham; J G Norman; T L Pruett
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.